Hypertension Diagnostics, Inc. (HDII)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 3.79 Million | 3.67 Million |
| Cost of Revenue | - | - | - | - | 2.83 Million | 2.92 Million |
| Gross Profit | - | - | - | - | 954.47 Thousand | 752.38 Thousand |
| Operating Expenses | - | 121.89 Thousand | 11 Thousand | 419.99 Thousand | 953.76 Thousand | 997.37 Thousand |
| Selling, General and Administrative Expenses | - | 121.89 Thousand | 11 Thousand | 419.99 Thousand | 917.76 Thousand | 966.07 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | 8257.00 | 8092.00 |
| Cost and Expenses | - | 121.89 Thousand | 11 Thousand | 419.99 Thousand | 3.79 Million | 3.92 Million |
| Operating Income | - | -121.9 Thousand | -11 Thousand | -419.99 Thousand | -160.97 Thousand | -403.49 Thousand |
| Interest Expense | - | - | - | - | 161.67 Thousand | 158.5 Thousand |
| Income Tax Expense | - | -228.48 Thousand | -236.55 Thousand | -206.29 Thousand | 169.93 Thousand | 166.59 Thousand |
| Earnings before Tax | - | -93.24 Thousand | -11 Thousand | 3.29 Million | -125.38 Thousand | -368.61 Thousand |
| Net Income | - | -93.24 Thousand | -11 Thousand | 3.29 Million | -125.38 Thousand | -368.61 Thousand |
| Earnings Per Share Basic | - | -0.00 | -0.00 | 0.02 | -0.00 | -0.00 |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | 0.02 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | - | 213.08 Million | 149.18 Million | 136.81 Million | 136.81 Million | 93.34 Million |
| Weighted Average Shares Outstanding (Diluted) | - | 213.08 Million | 149.18 Million | 136.81 Million | 136.81 Million | 93.34 Million |
| Gross Margin | - | - | - | - | 0.25 | 0.20 |
| EBIT Margin | - | - | - | - | 0.02 | -0.05 |
| Profit Margin | - | - | - | - | -0.03 | -0.10 |
| EBITDA | - | -93.24 Thousand | -11 Thousand | 3.29 Million | 36.7 Thousand | -178.8 Thousand |
| Earnings Before Tax Margin | - | - | - | - | -0.04 | -0.11 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 FY | 2023 Q1 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | 717.43 Thousand |
| Selling, General and Administrative Expenses | - | - | - | - | - | 717.43 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | - | - | - | - | 717.43 Thousand |
| Operating Income | - | - | - | - | - | -717.44 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | - | - | - | - |
| Earnings before Tax | - | - | - | - | - | -717.43 Thousand |
| Net Income | - | - | - | - | - | -717.43 Thousand |
| Earnings Per Share Basic | - | - | - | - | - | -0.00 |
| Earnings Per Share Diluted | - | - | - | - | - | -0.00 |
| Weighted Average Shares Outstanding | - | - | 284.78 Million | - | 284.78 Million | 284.78 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | 284.78 Million | - | 284.78 Million | 284.78 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | -717.44 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
EBCOF
BUR
009450
CRANE
3632
PTSH